Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.20    -0.20 (-0.23%)
Bid:
85.50
Ask:
88.00
Spread: 2.50 (2.924%)
Market Cap: £366.55m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

12 Jun 2014 07:00

RNS Number : 4014J
PZ CUSSONS PLC
12 June 2014
 



12 June 2014

PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc, a leading consumer products group, today issues the following trading update for the year ended 31 May 2014.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group for the year ended 31 May 2014 has been in line with management expectations with sterling profits* for the year expected to be approximately 6% higher than the previous year.

 

This result has been achieved despite a significant exchange impact of circa £12m from the translation and transactional effect of weakening currencies. Excluding this impact, profits* would have been 17% higher than the previous year.

 

The financial position of the Group remains strong with good cash generation and only a small net debt position at the year end.

 

Trading Update

 

Europe

 

In the UK washing and bathing division, Imperial Leather, Carex and Original Source have performed well driven by a significant renovation and innovation programme. The entire Imperial Leather range is being relaunched over the coming months with exciting new products, imagery and fragrances. Product portfolios have been optimised both for the big four supermarkets as well as further increasing distribution in other channels. The Cussons Mum & Me range is growing well together with new products under the Little Explorers sub-brand.

 

In the beauty division, consumer demand for St Tropez has been boosted by Kate Moss as brand ambassador. The Sanctuary, Charles Worthington and Fudge brands have performed well in the UK and have also now secured new overseas distribution.

 

In Poland, following the sale of the homecare brands in February for £46.6m in cash, focus is now on investing in and growing the personal care brands of Luksja, Original Source and Carex.

 

Performance in Greece has continued to show some improvement as the economy begins to stabilise.

 

Asia

 

Whilst profitability in Australia has been affected by the weaker Australian dollar, the core brands of Morning Fresh and Radiant have performed well. Rafferty's Garden has seen a number of new product launches and the international expansion will begin to be executed before the end of the calendar year.

 

Continued positive momentum in Indonesia has delivered another year of revenue growth although a weaker rupiah has impacted profits. Growth has been achieved across both the babycare and non-babycare portfolios as well as continued progress being made with distribution in other South East Asian territories.

 

Overall trading in the smaller territories of Thailand and the Middle East has been broadly in line with expectations.

 

Africa

 

In Nigeria, unrest in the North of the country has continued with increased levels of disruption over recent months. Economically, interest rates have been maintained at a high level reducing levels of liquidity in the trade. The naira has remained stable versus the US$, despite coming under pressure ahead of a change in the central bank governor.

 

In personal care and home care, whilst commodity products have had to trade in an extremely competitive environment, growth has been achieved in the value add portfolio driven by a significant brand renovation programme. Good growth has been achieved in the electricals business as well as in Nutricima, the nutritional beverage JV with Glanbia.

 

The palm oil joint venture with Wilmar has performed very well with the refinery already operating towards capacity and ahead of expectations. Good growth has been achieved in the consumer brands of Mamador and Devon Kings with the balance of output sold business to business.

 

Profitability in Ghana continues to be impacted by further weakening in the cedi. Kenya has performed well and in line with expectations.

 

Outlook

 

Whilst trading conditions in most markets remain challenging, the Group remains focussed on a dynamic and fast brand renovation and innovation programme, an ongoing cost reduction programme and successful delivery of new areas of growth such as Rafferty's Garden and the Wilmar joint venture.

 

These initiatives will help to offset the continuing macro challenges and the reduction in profits from Poland as a result of the homecare sale.

 

The Group's balance sheet remains strong and well placed to pursue new areas of growth.

 

Preliminary results

 

Preliminary results for the year ended 31 May 2014 will be announced on Tuesday 29 July 2014.

 

An analysts' presentation will be given at 9:30am on that day. This will be held at the new offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Dial in details will be available immediately following the Preliminary results announcement.

 

*profit before tax and exceptional items

- ENDS -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1027

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Toby Bates / Tim Linacre

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGURGQUPCGCG
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.